Assignee
OBSIDIAN THERAPEUTICS INC
US·7 granted patents·18 pending applications·49 citations·filing 2017–2024
Top patents by PatentIndex Score
25 records- 0193US11666642B2PDE5 compositions and methods for immunotherapyOBSIDIAN THERAPEUTICS INC·Filed 2022·Granted Jun 6, 2023·9 cites·26 claims
- 0292US11241485B2PDE5 compositions and methods for immunotherapyOBSIDIAN THERAPEUTICS INC·Filed 2018·Granted Feb 8, 2022·11 cites·26 claims
- 0390US11446398B2Regulated biocircuit systemsOBSIDIAN THERAPEUTICS INC·Filed 2017·Granted Sep 20, 2022·21 cites·7 claims
- 0487US12104178B2DHFR tunable protein regulationOBSIDIAN THERAPEUTICS INC·Filed 2021·Granted Oct 1, 2024·1 cites·7 claims
- 0587US11058725B2CA2 compositions and methods for tunable regulationOBSIDIAN THERAPEUTICS INC·Filed 2020·Granted Jul 13, 2021·5 cites·21 claims
- 0684US11629340B2DHFR tunable protein regulationOBSIDIAN THERAPEUTICS INC·Filed 2019·Granted Apr 18, 2023·2 cites·29 claims
- 0777US2024401004A1Dhfr tunable protein regulationOBSIDIAN THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0870US2024226158A9Administration of tumor infiltrating lymphocytes with membrane bound interleukin 15 to treat cancerOBSIDIAN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0967US2024075064A1Compositions and methods for expansion of t cells and tumor infiltrating lymphocytesOBSIDIAN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1063US2022133801A1Administration of tumor infiltrating lymphocytes with membrane bound interleukin 15 to treat cancerOBSIDIAN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1160US2024424136A1Compositions and systems for regulation of function/abundance and delivery of polypeptide payloadsOBSIDIAN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1259US2025186614A1Compact drug responsive domains for regulation of function/abundance and delivery of polypeptide payloadsOBSIDIAN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1358US2023233608A1Regulated biocircuit systemsOBSIDIAN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1455US2025134928A1Methods for identifying and using allogeneic tumor infiltrating lymphocytes to treat cancerOBSIDIAN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1551US12227551B2Membrane bound IL12 compositions and methods for tunable regulationOBSIDIAN THERAPEUTICS INC·Filed 2019·Granted Feb 18, 2025·0 cites·18 claims
- 1650US2022170011A1Compositions and methods for tunable regulation of cas nucleasesOBSIDIAN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1749US2022175781A1Cd40l compositions and methods for tunable regulationOBSIDIAN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1849US2022348937A1Compositions and methods for dhfr tunable protein regulationOBSIDIAN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1948US2022267398A1Ca2 compositions and methods for tunable regulationOBSIDIAN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2048US2021386788A1Er tunable protein regulationOBSIDIAN THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2146US2023092895A1Tandem cd19 car-based compositions and methods for immunotherapyOBSIDIAN THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2245US2023056856A1Compositions and methods for tunable regulation of transcriptionOBSIDIAN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2345US2022403001A1Pde5 derived regulatory constructs and methods of use in immunotherapyOBSIDIAN THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2445US2023026259A1Ca2 compositions and methods for tunable regulationOBSIDIAN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2543US2022259284A1Ca2 compositions and methods for tunable regulationOBSIDIAN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when OBSIDIAN THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →